Animal Cell Cultures - Expression and Engineering

Total Page:16

File Type:pdf, Size:1020Kb

Animal Cell Cultures - Expression and Engineering 9. Danish Conference on Biotechnology and Molecular Biology May 22-23, 2014 Hotel Munkebjerg, Vejle Animal Cell Cultures - Expression and Engineering Animal Cell Cultures - Expression and Engineering Front page image http://scitechdaily.com/microfluidic-system-precisely-measures-mammalian-cell-growth-rates/ 2 9. Danish Conference on Biotechnology and Molecular Biology May 22-23, 2014 Hotel Munkebjerg, Vejle Animal Cell Cultures - Expression and Engineering Over the last fifty years research in cell biotechnology has revealed substantial potentials for the production of bioactive proteins and use of the cells themselves particularly in medical applications. The development of efficient and safe processes for production of novel pharmaceuticals is of significant industrial importance and subject to extensive research efforts. The increasing availability of genome editing tools and genome sequences of mammalian cell factories, such as the Chinese hamster ovary cell, and other animal cell cultures enables for the first time a systems biotechnology driven approach to cell factory design. The conference will focus on - Perspectives in Animal Cell Factory Research - Expression and production systems - Technology platforms - Systems biology - Post translational modifications - Mammalian Cell Factories - Insect Cell Factories - Commercial perspectives and regulatory issues The conference includes a poster session covering a broad range of topics on biotechnology as well as a commercial exhibition of equipment, consumables and services to Danish biotechnology. 3 Animal Cell Cultures - Expression and Engineering Organisers Danish Biotechnological Society (DBS) is a scientific society established in 2006 in collaboration between Danish Biotechnology Forum and The Danish Society for Biochemistry and Molecular Biology. DBS is organised as part of The Danish Society of Engineers, IDA. The purpose of DBS is to facilitate networking within the field of biotechnology in Denmark, creating links between universities, research institutions, hospitals and companies. DBS represents professionals working with biotechnology and seeks to promote and communicate important issues on biotechnology, biochemistry and molecular biology to the public. DBS organises scientific conferences and meetings on biotechnology. Working group members - Anders Vagnø Pedersen, ALK-Abelló A/S - Catharina Stenholm, Novozymes A/S - Inge Kjærbølling, Society for Biological Engineering at Technical University of Denmark - Holti Kellezi, Synapse, University of Copenhagen - Jens Gram, CMC Biologics - Jochen Förster, Technical University of Denmark - Lars Haastrup Pedersen, Aalborg University - Leif Schauser, CLC Bio - Nils Joakim Færgeman, University of Southern Denmark - Steen Gammeltoft, Glostrup Hospital - Stephanie Mesker, Technical University of Denmark - Thomas Schou Larsen, Biopeople – Innovation - Uffe Hasbro Mortensen, Technical University of Denmark Co-organisers The conference is organised in collaboration with Danish Society of Biochemistry and Molecular Biology as well as BioPeople Secretariat Birgitte Magnér-Egeberg, IDA Netværkscenter, Kalvebod Brygge 31-33, DK-1780 Kbh. V. Tel: 33 18 46 46, e- mail: [email protected] 4 Program 5 Animal Cell Cultures - Expression and Engineering May 22 9.00 – 9.50 Registration, coffee and tea 9.50 – 10.00 Welcome by Lars Haastrup Pedersen, DBS, DK 10.00 – 11.00 Session 1 Perspectives in Animal Cell Factory Research chair: Lars Haastrup Pedersen, Aalborg University, DK 10.00 – 10.30 The genome area of CHO: from blackbox optimisation to designer cell lines? L1.1 Nicole Borth, University of Natural Resources and Life Sciences, AUT 10.30 – 11.00 Microparticles as cell-to-cell communicators to empower therapies and technology: L1.2 the case of megakaryocytic micro particles Terry Papoutsakis, University of Delaware, USA 11.00 – 13.00 Posters and exhibition, meet the speakers, and lunch 13.00 – 14.00 Session 2 Cell engineering and post-transcriptional mechanisms chair:, Thomas Schou Larsen, BioPeople, DK 13.00 – 13.30 Screening of small RNAs for impact on apoptosis and protein expression in cell cultures L2.1 Michael Betenbaugh, Johns Hopkins University ,USA 13.30 – 14.00 Efficient precise glycoengineering of cellular post translational modification pathways L2.2 Eric Paul Bennett, Copenhagen University, DK 14.00 – 15.00 Posters and exhibition, meet the speakers, hotel check in 15.00 – 16.00 Session 3 Expression and Production Systems chair: Jens Gram, CMC Biologics, DK 15.00 –15.30 The cultural divide: exponential growth in classical 2D and metabolic equilibrium in 3D environments Jonathan D. Chesnut, Thermo Fisher Scientific, USA L3.1 15.30 – 16.00 Accelerating Genome Editing in CHO Cells using CRISPR CAS9 L3.2 Helene Faustrup Kildegård, Technical University of Denmark, DK 16.00 – 17.00 Posters and exhibition, meet the speakers 17.00 – 18.00 Session 3 cont. Expression and production in CHO cells chair: Leif Schauser, CLC Bio, DK 17.00 – 17.30 CHO cell engineering for improved therapeutic protein production L3.3 Gyun Min Lee, KAIST, KOR 17.30 – 18.00 Large-scale transient gene expression platforms using HEK293 and CHO cells for protein production L3.4 Yves Durocher, Animal Cell Technology Research Group, National Research Council, CAN 18.00 – 19.00 Posters and exhibition, meet the speakers 19.30 – Conference dinner 6 May 23 8.30 – 9.30 Session 4 Insect Cell Factories chair: Leif Schauser, CLC Bio, DK 8.30 – 9.00 Development of Drosophila S2 insect-cell based Malaria Vaccine production processes L4.1 Wian de Jongh, ExpreS2ion Biotechnologies, DK 9.00 – 9.30 The state-of-play of baculovirus-mediated protein expression in insect cells L4.2 Svend Kjær, London Research Institute, UK 9.30 – 10.30 Posters and exhibition, meet the speakers, hotel check out 10.30 – 11.45 Session 5 Mammalian Cell Culture Production Systems chair: Nils Færgeman, University of Southern Denmark, DK 10.30 – 10.55 Industrial production systems L5.1 Jens Gram, CMC Biologics, DK 10.55 – 11.20 Cell cultures on chip - possibilities and challenges L5.2 Martin Dufva, Department of Micro- and Nanotechnology, Technical University of Denmark, DK 11.20 – 11.45 Bioprocess cost modeling guiding early stage process development L5.3 Kai M. Touw, Crucell, NL 11.45 – 13.15 Lunch, posters and exhibition, meet the speakers 13.15 – 14.05 Session 6 Regulatory Issues and Commercial Perspectives chair: Thomas Schou Larsen, BioPeople, DK 13.15 – 13.40 Regulatory Environment of White Biotechnology with a Shade of Red L6.1 Carsten Hjort, Novozymes A/S, DK 13.40 – 14.05 Biological engineering – a stronghold in Danish biotech L6.2 Martin Bonde, Dansk Biotek 14.05 – 14.40 Posters and exhibition, meet the speakers 14.40 – 15.55 Session 7 Mammalian Cell Factories and Systems biology chair: Mikael Rørdam Andersen, Technical University of Denmark, DK 14.40 – 15.05 Engineering Biological Networks in CHO Cell Lines L7.1 Mikael Rørdam Andersen, Department of Systems Biology, Technical University of Denmark, DK 15.05 – 15.30 In-vivo like performance of microgravity spheroids in-vitro L7.2 Stephen J. Fey, University of Southern Denmark, DK 15.30 – 15.55 Towards Holistic Biotechnology – L7.3 An Industrial Perspective on Next Generation Cell Culture Processes Ali Kazemi Seresht Cell Culture Technology, Novo Nordisk A/S, DK 15.55 – 16.00 Closing remarks Lars Haastrup Pedersen, DBS, DK 7 Animal Cell Cultures - Expression and Engineering 8 Lecture abstracts 9 Animal Cell Cultures - Expression and Engineering 10 L1.1 The genome area of CHO: from blackbox optimisation to designer cell lines? Nicole Borth University of Natural Resources and Life Sciences Vienna (BOKU) and Austrian Center of Industrial Biotechnology (ACIB), Austria During the last 25 years, recombinant protein production in Chinese Hamster Ovary cells has reached a level of optimisation that has turned it into an “established technology”. Indeed, the improvements in yields achieved are remarkable: titers have increased from 0.1-0.4 g/l to reliable 2-6 g/l, with top values of 20 g/l reported. Nevertheless this achievement was based on empirical approaches and was largely due to enhancements of the medium composition and the higher cell densities thus reached. Details of what happened inside the cells have remained mostly a blackbox, despite the advances accomplished. With the availability of a genomic sequence, both of several CHO cell lines and the reference genome from the Chinese hamster, there now is the opportunity to accomplish a step change in our understanding and control of both the bioprocesses and cell behaviour. In parallel, new tools and methods are emerging that enable precise genome and epigenome editing, which together with the sequence information will enable the generation of designer cell lines, with precisely edited properties for different product categories. The present talk will give an overview over the available CHO databases and sequences and will then focus on how this genomic information can be used to obtain a comprehensive understanding of the regulatory network in place in this industrially used production cell line. In addition, the currently discussed plans for development of infrastructure and software to be available at www.CHOgenome.org will be discussed. 11 Animal Cell Cultures - Expression and Engineering L1.2 Microparticles as cell-to-cell communicators to empower therapies and technology: the case of megakaryocytic microparticles Eleftherios Terry Papoutsakis & Jinlin Jiang University of Delaware, USA A
Recommended publications
  • OECD Reviews of Regional Innovation OECD Reviews of Regional Central and Southern Denmark
    OECD Reviews of Regional Innovation Regional of Reviews OECD Central and Southern Denmark Contents OECD Reviews of Regional Innovation Assessment and recommendations Introduction Central Chapter 1. Innovation and the economies of Central and Southern Denmark Chapter 2. Danish governance and policy context for regional strategies and Southern Denmark I Chapter 3. Regional strategies for innovation-driven growth nnovation C e nt r al an al d So uth er n D n Please cite this publication as: e OECD (2012), OECD Reviews of Regional Innovation: Central and Southern Denmark 2012, nma OECD Publishing. http://dx.doi.org/10.1787/9789264178748-en r k This work is published on the OECD iLibrary, which gathers all OECD books, periodicals and statistical databases. Visit www.oecd-ilibrary.org, and do not hesitate to contact us for more information. isbn 978-92-64-17873-1 04 2012 09 1 P -:HSTCQE=V\]\XV: 042012091.indd 1 08-Aug-2012 2:19:29 PM OECD Reviews of Regional Innovation: Central and Southern Denmark 2012 This work is published on the responsibility of the Secretary-General of the OECD. The opinions expressed and arguments employed herein do not necessarily reflect the official views of the Organisation or of the governments of its member countries. This document and any map included herein are without prejudice to the status of or sovereignty over any territory, to the delimitation of international frontiers and boundaries and to the name of any territory, city or area. Please cite this publication as: OECD (2012), OECD Reviews of Regional Innovation: Central and Southern Denmark 2012, OECD Publishing.
    [Show full text]
  • Report on Large Scale Scientific Research Institutions in BSR
    Study of Co-Operation between Entrepeurship and Scientific Infrastructure in Baltic Sea Region Riga, 2013 Researcher: SIA „Baltijas Konsultācijas” P. 673-388-04 Fax: 660-020-57 E-mail: [email protected] www.Balticconsulting.com 1/97 CONTENT CONTENT ......................................................................................................................................................... 1 1. LIST OF ABBREVIATIONS .............................................................................................................................. 3 2. LIST OF CHARTS, FIGURES AND TABLES ...................................................................................................... 4 3. METHODOLOGY .......................................................................................................................................... 5 4. RESEARCH INFRASTRUCTURE AND THE EUROPEAN UNION ....................................................................... 8 5. SCIENCE INFRASTRUCTURE IN THE BALTIC SEA REGION ........................................................................... 10 5.1. COLLABORATION IN R&D IN BSR .............................................................................................................. 10 5.2. FINANCIAL RESOURCE ALLOCATION FOR R&D IN THE BSR .............................................................................. 12 5.3. SPECIALIZATION AREAS IN THE BSR COUNTRIES ............................................................................................ 13 SUMMARY ............................................................................................................................................................
    [Show full text]
  • Science, Technology and Innovation in Europe
    2016 Science, Technology and Innovation in Europe 2016 Science, Technology and Innovation in Europe EU, The world's True Mecca of Science, Technology and Innovation Foreword I would like to share with Republic of Korea the excellence of the EU in research, science and innovation as well as the wide range of relevant programmes underway, through the publication of this book. Science, Technology and Innovation play a pivotal role in shaping industry and the economy in the twenty-first century. They provide instruments to solve many of the economic and social challenges and problems we face today. In recognition of the importance of science and technology and its strong influence on all walks of life, the European Union (EU) has long emphasised the need for innovation as a vehicle for promoting stable and sustainable economic development and enabling a quantum leap toward a better society. With just 7% of the world’s population, the EU takes up respectively 24% and 32% of the global R&D expenditure and patent applications. This is a result of the EU’s persistent and intensive support for science and technology over the long-term. On the back of the abundant knowhow so far accumulated and excellent human resources, the EU is indeed the world’s true mecca of science, technology and innovation. Within the overarching policy objective of providing a solid foundation for the economy as a whole by maintaining excellence in science and research, the EU has launched a new and ambitious research and innovation support programme, “Horizon2020”. The programme is aimed at supporting research and innovation projects from 2014 to 2020 on a multilateral basis.
    [Show full text]
  • State of Medicon Valley 2016
    STATE OF MEDICON VALLEY 2016 An Analysis of Life Science in Greater Copenhagen PREFACE Life science in Denmark and Sweden has developed in different directions over the past decade. Danish life science exports doubled in seven years, and last year they were nearly 50% greater than Swedish. The number of employees has risen, and thanks to a well-developed system with industrial foundations, the large companies’ headquarters and major shareholders are still in Denmark. At the same time in Sweden, more large companies are now foreign-owned, the largest headquarters have left the country and more important operations have either shrunken in scale or closed down, and the number of employees in the sector has diminished. But there are signs of a change for the better in the university city Lund as well as in Södertälje, Stockholm and Uppsala, visible with for example new biotechnology companies, new research facilities and new investments in the R&D of biological medicines. It is part of a new phase in the life science sector’s global transition, and it is also perceptible in Denmark as the simultaneous reports of cutbacks and the hiring of new competence. Medicon Valley Alliance is also in a transitional phase, with a new strategy that focuses more on our role as a networking organisation for the life science cluster on both sides of the Öresund. Part of our upgraded ambition is to increase knowledge about the compa- nies and research in Medicon Valley. This is the first edition of our new annual analytic report State of Medicon Valley, which offers a unique presentation of life science develop- ments in our region, on a macro- as well as a micro-scale.
    [Show full text]
  • International Conference on Research Infrastructures Copenhagen, 21–23 March 2012
    PARTICIPANTS International Conference on Research Infrastructures Copenhagen, 21–23 March 2012 WWW.ICRI2012.DK PARTICIPANTS AT ICRI 2012 SPEAKERS Name Organisation Country Ana ARANA ANTELO European Commission Belgium Pauline BEATTIE EDCTP Netherlands Sergio BERTOLUCCI CERN Switzerland Flemming BESENBACHER The Carlsberg Foundation and Interdiscipli- Denmark nary Nanoscience Center (iNANO), Aarhus University Juan Carlos BICARREGUI Science and Technolgy Facilities Council United Kingdom Henrik BINDSLEV Aarhus University Denmark Alan BLATECKY National Science Foundation USA James H. BUTLER NOAA Earth System Research Laboratory USA Mario CAMPOLARGO European Commission Belgium Colin James CARLILE European Spallation Source ESS AB Sweden Ian CHUBB Office of the Chief Scientist Australia Willem Abraham CRONJE University of the Witwatersrand South Africa Joanne Christine DALY CSIRO Australia Jacques DEMOTES MAINARD INSERM France Daan DU TOIT South African Department of Science and South Africa Technology Gabriele FIONI Ministry for Higher Education and Research France Isabel FORTIER MCGIll University Health Center and P3G Canada Consortium Rhys Steven FRANCIS Australian eResearch Infrastructure Council Australia Dagmar Ingeborg FRITZE Leibniz-Institut DSMZ-Deutsche Sammlung Germany von Mikroorganismen und Zellkulturen GmbH Chad GAFFIELD Social Sciences and Humanities Research Canada Council of Canada Martin GALLAGHER Australian Embassy Brussels Australia Nirmal Kumar GANGULY Department of Biotechnology, National Insti- India tute of Immunology
    [Show full text]
  • Copenhagen April 19, 2017 Dear President Juncker, President Tusk
    Copenhagen April 19, 2017 Dear President Juncker, President Tusk, and President Tajani, Over the coming months, the decision on where to relocate the European Medicines Agency (EMA) will be on the table for you as a European decision-maker. We are representatives of a broad coalition of public and pri- vate institutions in Denmark deeply involved in and dependent on a well-functioning European medicines authority. We believe Copenhagen offers optimal conditions for hosting the EMA thanks to the presence of a world-class research environment, an innovative and vibrant life science cluster, a unique basis for a strong focus on patient and animal safety, an efficient infrastructure, and high liveability for employees and their families. Allow us to elaborate. Less known than Silicon Valley is Europe’s own Medicon Valley in the Greater Copenhagen area. Comprising 28 hospitals of which 11 are university hospitals, three world-class universities, hundreds of biotech and pharmaceutical companies from around the globe, and Copenhagen Airport at the centre, it is a scientific stronghold for the EU. Copenhagen, thus, offers an exceptional research and innovation ecosystem; the key pillars being strong public research environments, innovative life-science cluster and a very successful phar- maceutical and medtech industry. A strong tradition for public-private collaboration between universities, hospitals and the life science industry is characteristic for the region. Placing EMA in Copenhagen would fur- ther strengthen the EU’s global position in this field. Importantly, the institutions, universities and hospitals in the area ensure that there is a highly competent and professionally skilled workforce ready for EMA to tap into at any given time.
    [Show full text]
  • Redefining the Food Sector in the Øresund Region 6
    REDEFINING THE FOOD SECTOR PART I: PART II: The modern food industry Food research, education in the Øresund Region, a and collaboration in the statistical approach Øresund Region Published by Øresund Food Author part I: Nils-Olof Jönsson, Author part II: Maria Nyberg Edited by: Mie Bendtsen, Heidi Høy Dyrholm & Maura Loughney Support from The European Regional Development Fund Vækstforum Hovedstaden Interreg IVA Layout Monoline Copyright Authors ISBN: 978-87-7349-792-0 2 REDEFINING THE FOOD SECTOR CONTENTS FOREWORD 5 REDEFINING THE FOOD SECTOR IN THE ØRESUND REGION 6 PART I REDEFINING THE FOOD SECTOR: THE MODERN FOOD INDUSTRY IN THE ØRESUND REGION, A STATISTICAL APPROACH 9 1. INTRODUCTION 10 1.1 Aim and focus of the report 10 1.2 Disposition 10 2. DEFINITIONS, STATISTICAL DATA AND GEOGRAPHY 12 2.1 Standard definitions of the food industry 12 2.2 Definitions of food industry, food cluster and food industry cluster 13 2.3 Statistical classification standards 14 2.4 Primary and secondary data 16 2.5 Geographical focus 17 3. OUR MODEL FOR REDEFINITION OF THE FOOD INDUSTRY 18 4. ANALYSIs – INDUSTRY BY INDUSTRY 20 4.1 Food industry core 20 4.2 First level support 24 4.3 Second level support 26 4.4 Independent operators 30 5. REACHING THE NEW DEFINITION OF THE MODERN FOOD INDUSTRY 31 5.1 Adjustments 31 5.2 The new, modified model to describe the food industry 32 6. THE FOOD INDUSTRY AROUND ØRESUND 34 6.1 The food industry cluster employs more than double the number generally perceived 34 6.2 Denmark and Scania embrace a complete food industry cluster 38 7.
    [Show full text]
  • Project 9 Translating Research for Economic and Social Benefit: Country Comparisons
    This report can be found at www.acola.org.au © Australian Council of Learned Academies Securing Australia’s Future - Project 9 Translating research for economic and social benefit: country comparisons Denmark A Study of Measures to Encourage the Translation of Public Sector Research for Economic and Social Benefit in Denmark Professor Ron Johnston FTSE Australian Centre for Innovation Suggested Citation Johnston, R (2015). A Study of Measures to Encourage the Translation of Public Sector Research for Economic and Social Benefit in Denmark. Report for Securing Australia’s Future Project “Translating research for economic and social benefit: country comparisons” on behalf of the Australian Council of Learned Academies, www.acola.org.au. © Australian Council of Learned Academies (ACOLA) This work is copyright. All material published or otherwise created by Australian Council of Learned Academies (ACOLA) is licensed under a Creative Commons Attribution- NonCommercial 4.0 International License. This report can be found at www.acola.org.au © Australian Council of Learned Academies Table of Contents 1. Introduction .................................................................................................................................... 3 1.1. The Act on Innovation Fund Denmark states that it: .............................................................. 7 2. Specific Programs ............................................................................................................................ 8 2.1. Innovation Fund Denmark (IFD)
    [Show full text]
  • TOWARDS an INTERNATIONAL FOOD CLUSTER in DENMARK an Analysis of the Food Sector in Central Denmark Region
    TOWARDS AN INTERNATIONAL FOOD CLUSTER IN DENMARK An analysis of the food sector in Central Denmark Region Glenda Napier and Henrik Bjerregaard, REG X – The Danish Cluster Academy CONTENTS 3 Foreword 4 Summary 5 About the analysis 6 Introduction 9 Method and scope 11 Areas of business specialisation within Central Denmark Region’s food sector 17 Key figures for food activities in Central Denmark Region 20 The food activity ecosystem and stakeholders in Central Denmark Region 30 Development of a strong cluster 33 Recommendations 37 Appendix Idea & layout: Trine Vu, www.hungogvu.com Vu, Trine Idea & layout: TOWARDS AN INTERNATIONAL FOOD CLUSTER IN DENMARK // REG X | 2 FOREWORD ince 2007, the Central Denmark Growth Forum has ness development effort is to make a difference to business, made big efforts to develop strong development en­ including the food industry. vironments and boost the innovation competencies S of food companies. This has taken place in recogni­ With this smart specialisation analysis, focusing on cluster tion of the great business-political significance of the food development, Central Denmark Region, Agro Food Park, Fu­ industry for the region and the need for companies to be ture Food Innovation and REG X have taken the first step adaptable and innovative in view of developments on the towards developing the future regional action plan for the global market. Public and private stakeholders have sup­ food sector – an action plan set in a national context with ported the initiative. In this, the establishment of Agro Food a clear global direction. We will, of course, also participate Park and Future Food Innovation has played an important in the exciting and necessary work underway within Food­ role in highlighting the innovative power of Central Den­ best, which aims to create a strong position for Danish food mark’s food environment.
    [Show full text]
  • State of Medicon Valley 2020
    MORE THAN 200 CORONA VIRUS-PROJECTS AT UNIVERSITIES AND HOSPITALS IN MEDICON VALLEY, PAGE 44 STATE OF MEDICON VALLEY 2020 An Analysis of Life Science in Greater Copenhagen STATE OF MEDICON VALLEY 2020 An Analysis of Life Science in Greater Copenhagen PREFACE Commissioned and published by: Medicon Valley Alliance. The coronavirus pandemic has changed the conditions surrounding many things in Med- This analysis has been prepared by Øresundsinstituttet and icon Valley. The number of personal meetings between researchers, clients, investors was written by Jenny Andersson, Anna Palmehag, and companies over national borders has declined, and the development toward more Thea Wiborg and Johan Wessman. digital meetings has accelerated. Moving between countries has become more difficult Project manager: Jenny Andersson. for international students. Nevertheless, the region’s universities and businesses have Translation: Justina Bartoli. demonstrated the vast competence housed in Medicon Valley by actively taking part in the Coverphoto: Astra Zeneca development of vaccines and drugs to prevent and treat covid-19. As pages 44-45 show, over 200 research projects have been launched at universities and hospitals in Medicon November 2020 Valley. In addition, many businesses in the region are venturing into corona research, either with universities or on their own. Fortunately, life science exports are going well. In 2019, Danish life science exports reached a record-high of 133 billion DKK – a 25 per cent increase from the previous year, TABLE OF CONTENTS which had also been a record-breaker. Danish life science is often foregrounded as a natio- nal strength, as the sector fares well in times of crisis and helps create stability.
    [Show full text]
  • State of Medicon Valley 2019
    STATE OF MEDICON VALLEY 2019 An Analysis of Life Science in Greater Copenhagen PREFACE STATE OF MEDICON VALLEY 2019 The winds of change continue to blow through Medicon Valley and the Danish and Swedish life science industry. The region’s life science industry is still expanding, and new products An Analysis of Life Science in Greater Copenhagen are being launched, although turnover in the region’s largest pharmaceutical companies has temporarily plateaued. Novo Nordisk Foundation’s endeavour to establish a world-class inn- Commissioned and published by: Medicon Valley Alliance. ovation environment at COBIS in Copenhagen is progressing with the BioInnovation Institute. This analysis has been prepared by Øresundsinstituttet and Medeon Science Park in Malmö is expanding with the new structure Forskaren 1, and Lund’s was written by Jenny Andersson, Anna Palmehag, Medicon Village just inaugurated its newly constructed building The Spark. Thea Wiborg and Johan Wessman. Project manager: Jenny Andersson. Pharmaceutical exports are still rising. Between 2017 and 2018, Swedish life science Translation: Justina Bartoli. exports increased by 10.6%; in the same period, Danish life science exports increased by Coverphoto: News Øresund 7.7%. According to Statistics Denmark, the Danish pharmaceutical industry grew over 20% between November 2017 and June 2019, and the sector now makes up one-fifth of Den- November 2019 mark’s industrial production. As the life science sector has grown more important for both the Danish and Swedish national economies, and with the increasing pressure on public healthcare systems in both countries, political interest has also grown. Denmark now has an internationalisation strategy for health and the life sciences, and the Swedish government presented an eight-point programme that forms the backbone for the upcoming Swedish life TABLE OF CONTENTS science strategy.
    [Show full text]
  • LIFE SCIENCE ACROSS the ØRESUND – a Survey of Transregional Commuters, Actors, Research and Investments
    LIFE SCIENCE ACROSS THE ØRESUND – a survey of transregional commuters, actors, research and investments 900 border commuters in Medicon Valley At least 20 Danish CEOs at companies in Skåne 13 Danish companies listed in Sweden since 2014 PREFACE The Danish-Swedish life science cluster that spans over the Øresund, Medicon Valley, is linked together by all of the engaged individuals who work at the universities, hospitals, research centres and all of the LIFE SCIENCE ACROSS THE ØRESUND companies in the region. As part of the Interreg-project Greater Copenhagen Life Science Analysis Initiative, – a survey of transregional commuters, actors, Øresundsinstituttet has surveyed networks, collaborations, investments, ownership and personal contacts research and investments in Medicon Valley. More than 900 people employed at companies in the life science cluster commute across the Øresund Strait, This analysis has been prepared by Øresundsinstituttet as part of the Interreg- most of them from Skåne to Danish companies such as Novo Nordisk, Ferring, LEO Pharma, Lundbeck and project Greater Copenhagen Life Science Analysis Initiative and was written by Genmab. The growing group of companies from Skåne – frequently small and listed in Sweden – is also hel- Jenny Andersson, Kristoffer Dahl Sørensen, Sofi Eriksson and Johan Wessman. ping itself to the generous offering of skilled business leaders schooled in the large life science companies across the strait in Denmark. Today, more than 20 life science companies in Skåne are headed by a Danish Project manager for analytics: Jenny Andersson CEO. Ultimately, in and around Copenhagen is where Medicon Valley’s largest life science companies are. Overall project manager: Johan Wessman The Danish system of large, foundation-owned companies means that power over the company remains in Denmark, even if it is publicly traded, and it also means that part of the company’s profits return to research Translation: Justina Bartoli and new startups via the foundations that own them.
    [Show full text]